Asia Deal Watch: Cipla’s Latest Diabetes Partner In India Is Boehringer Ingelheim
Executive Summary
Also, deals involving Sumitomo Dainippon, Tolero, Boston Biomedical, Zai Lab, Turning Point, SciClone, EpicentRx, Yuhan, GI Innovation, Takeda, Carmine, HitGen, Morphic, CStone and Burning Rock.
You may also be interested in...
Pfizer Joins Singapore Initiative To Support Regional Startups
US pharma giant joins Singapore alliance aiming to encourage regional startups and innovation, in multiple tech-related areas including digital health, through the provision of expertise and support.
KKR Deal To Bolster JB Chemicals’ Expansion Efforts
US private equity firm KKR to acquire a majority stake in JB Chemicals, accelerating the Indian group's growth plans in branded formulations. Post a 54% stake acquisition for $414m via part-purchase from the founders and an open offer at INR745/share, KKR's final stake could rise to 64.9% if founders offer more shares.
Tripartite Avigan Alliance Aims For Global Access
Fujifilm Toyama seals three-way deal to accelerate the development and global supply of favipiravir, close on the heels of the arrival of a generic version of the antiviral in India under restricted emergency use for the treatment of COVID-19.
Need a specific report? 1000+ reports available
Buy Reports